Skip to content
← Clinical Cases

Centrally Acting Analgesics — clinical cases

30 questions

Sample cases

  1. Case 1

    A pharmacy student asks how tramadol produces analgesia. Which description is most accurate?

    • A.It is a mu-opioid agonist, mainly through its O-desmethyl metabolite (M1), and also weakly inhibits serotonin and norepinephrine reuptake
    • B.It is a selective cyclooxygenase-2 inhibitor in the central nervous system with weak mu-opioid agonist activity
    • C.It blocks NaV1.8 sodium channels in peripheral sensory neurons and has no opioid receptor activity
    • D.It is a mu-opioid antagonist whose analgesia comes entirely from blocking norepinephrine reuptake
  2. Case 2

    A 58-year-old man with chronic low back pain had almost no relief from tramadol 50 mg every 6 hours for 3 weeks. Pharmacogenomic testing shows he is a CYP2D6 poor metabolizer. His renal and hepatic function are normal. If an opioid-class analgesic is still needed, which option's analgesic effect is LEAST dependent on CYP2D6 activity?

    • A.Codeine
    • B.Tramadol extended-release
    • C.Tapentadol
    • D.Tramadol/acetaminophen
  3. Case 3

    A 69-year-old woman with knee osteoarthritis is to start immediate-release tramadol. She does not need rapid pain relief, and she had marked nausea and dizziness when she tried another opioid. Which starting plan matches the tramadol label's titration to improve tolerability?

    • A.50–100 mg every 4–6 hours as needed from the first day, up to a maximum of 400 mg/day
    • B.25 mg daily, up 25 mg every 3 days to 25 mg four times daily, then 50 mg/day every 3 days to 200 mg/day
    • C.100 mg every 12 hours from day 1, then doubled to 200 mg every 12 hours after 1 week if pain persists
    • D.50 mg four times daily from the first day, doubled every 3 days until pain is controlled